Test Bank For Pharmacotherapeutics for Advanced Nursing
Practice EXAM with Questions and Answers/Plus a
Rationale Updated 2026 A+/Instant Download PDF
EXAM COVERAGE
1. Principles of Pharmacokinetics and Pharmacodynamics
2. Cardiovascular Pharmacotherapeutics
3. Pharmacotherapy for Respiratory Disorders
4. Endocrine System and Metabolic Pharmacotherapy
5. Infectious Disease and Antimicrobial Stewardship
6. Neurological and Psychiatric Pharmacotherapy
7. Gastrointestinal and Renal Pharmacotherapy
8. Pain Management and Analgesics
9. Hematology and Oncology Pharmacotherapy
10. Pharmacotherapy for Special Populations (Geriatrics/Pediatrics/Pregnancy)
1. A 68-year-old patient with heart failure takes digoxin. They are prescribed clarithromycin for a
sinus infection. What is the most critical physiological concern regarding this drug-drug
interaction?
A. Inhibition of CYP3A4 leading to decreased digoxin metabolism
B. Inhibition of P-glycoprotein, increasing digoxin bioavailability and risk of toxicity
, C. Induction of P-glycoprotein, reducing digoxin therapeutic effect
D. Competition for renal tubular secretion, causing hyperkalemia
CORRECT ANSWER : B
Rationale: Clarithromycin is a potent inhibitor of P-glycoprotein, an efflux transporter in the gut
and kidneys. Inhibiting this transporter leads to significantly increased absorption and
decreased renal clearance of digoxin, a narrow therapeutic index drug, placing the patient at
high risk for digitalis toxicity. Options A, C, and D are incorrect because digoxin is not
primarily metabolized by CYP3A4, and the primary mechanism of this specific interaction is P-
glycoprotein inhibition, not induction or tubular secretion competition causing hyperkalemia.
2. A patient presents with Type 2 Diabetes and a history of chronic heart failure (NYHA Class III).
Which medication should be avoided as first-line therapy?
A. Metformin
B. Empagliflozin
C. Pioglitazone
D. Sitagliptin
CORRECT ANSWER : C
Rationale: Pioglitazone is a thiazolidinedione that causes fluid retention, which can exacerbate
or precipitate congestive heart failure. Metformin is generally the first-line choice;
Empagliflozin is beneficial in heart failure; Sitagliptin is weight-neutral and safe in heart failure.
Option C is the only choice that poses a direct, clinically significant risk of worsening heart
failure due to sodium and water retention.
3. Which mechanism of action best explains the efficacy of SSRIs in the treatment of major
depressive disorder, despite the rapid increase in synaptic serotonin?
A. Downregulation of postsynaptic serotonin receptors
B. Inhibition of MAO-A in the synaptic cleft
C. Desensitization and downregulation of presynaptic 5-HT1A autoreceptors
D. Immediate increase in brain-derived neurotrophic factor (BDNF)
CORRECT ANSWER : C
, Rationale: The delayed clinical response to SSRIs is attributed to the time required for the
presynaptic 5-HT1A autoreceptors to desensitize and downregulate due to chronic exposure to
increased synaptic serotonin. This removal of the "negative feedback" inhibition allows for
sustained, enhanced firing of serotonergic neurons. Options A, B, and D do not accurately
describe the primary mechanism explaining the therapeutic lag of SSRIs.
4. A patient on warfarin for atrial fibrillation is diagnosed with a DVT and requires a significant
change in diet involving high intake of leafy greens. How should the clinician adjust the
monitoring plan?
A. Increase warfarin dose immediately to compensate for vitamin K intake
B. Discontinue warfarin and switch to a DOAC
C. Monitor INR closely and adjust warfarin dose based on steady-state intake patterns
D. Prescribe prophylactic vitamin K supplementation
CORRECT ANSWER : C
Rationale: Sudden changes in dietary vitamin K intake can significantly impact INR, but the goal
is consistency rather than avoidance. The clinician must monitor the INR to determine if the new
dietary pattern has shifted the patient's requirement. Increasing the dose (A) without data is
dangerous; switching to a DOAC (B) may be an option but doesn't address the current
management; prophylactic vitamin K (D) is not the standard approach for dietary management.
5. When prescribing a beta-blocker for a patient with asthma, which agent is preferred due to its
pharmacokinetic profile?
A. Propranolol
B. Metoprolol succinate
C. Carvedilol
D. Nadolol
CORRECT ANSWER : B
Rationale: Metoprolol succinate is a cardioselective (beta-1) blocker and is less likely to cause
bronchoconstriction at lower doses compared to non-selective agents. Propranolol, Carvedilol,
and Nadolol are non-selective (blocking both beta-1 and beta-2 receptors) and pose a significant
risk of inducing bronchospasm in patients with reactive airway disease.
6. A patient is prescribed vancomycin for MRSA. What is the pharmacological basis for monitoring
trough levels?
, A. To prevent infusion-related anaphylaxis
B. To ensure peak concentrations exceed the MIC
C. To maintain therapeutic drug concentration while minimizing the risk of nephrotoxicity
D. To track the elimination half-life of the drug in real-time
CORRECT ANSWER : C
Rationale: Vancomycin-associated nephrotoxicity is strongly correlated with high trough
concentrations (typically >15-20 mcg/mL). Monitoring troughs ensures the drug reaches
effective concentrations for bacterial clearance without exceeding the safety threshold for renal
tubular injury. Options A, B, and D are incorrect as they do not represent the clinical rationale
for steady-state trough monitoring.
7. A patient with Parkinson’s disease develops psychotic symptoms. Which agent is the most
appropriate to manage these symptoms with the least risk of worsening motor function?
A. Haloperidol
B. Risperidone
C. Olanzapine
D. Pimavanserin
CORRECT ANSWER : D
Rationale: Pimavanserin is a selective serotonin inverse agonist (SSIA) that acts on 5-HT2A
receptors and does not exhibit appreciable affinity for dopamine receptors, making it ideal for
Parkinson's disease psychosis. Haloperidol, Risperidone, and Olanzapine are dopamine
antagonists that worsen motor symptoms by blocking D2 receptors in the nigrostriatal pathway.
8. Which mechanism accounts for the increased risk of hyponatremia when using Selective
Serotonin Reuptake Inhibitors (SSRIs) in elderly patients?
A. Enhanced ADH secretion via central serotonin stimulation
B. Renal sodium wasting due to prostaglandin inhibition
C. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
D. Reduced aldosterone sensitivity in the distal convoluted tubule
CORRECT ANSWER : C
Practice EXAM with Questions and Answers/Plus a
Rationale Updated 2026 A+/Instant Download PDF
EXAM COVERAGE
1. Principles of Pharmacokinetics and Pharmacodynamics
2. Cardiovascular Pharmacotherapeutics
3. Pharmacotherapy for Respiratory Disorders
4. Endocrine System and Metabolic Pharmacotherapy
5. Infectious Disease and Antimicrobial Stewardship
6. Neurological and Psychiatric Pharmacotherapy
7. Gastrointestinal and Renal Pharmacotherapy
8. Pain Management and Analgesics
9. Hematology and Oncology Pharmacotherapy
10. Pharmacotherapy for Special Populations (Geriatrics/Pediatrics/Pregnancy)
1. A 68-year-old patient with heart failure takes digoxin. They are prescribed clarithromycin for a
sinus infection. What is the most critical physiological concern regarding this drug-drug
interaction?
A. Inhibition of CYP3A4 leading to decreased digoxin metabolism
B. Inhibition of P-glycoprotein, increasing digoxin bioavailability and risk of toxicity
, C. Induction of P-glycoprotein, reducing digoxin therapeutic effect
D. Competition for renal tubular secretion, causing hyperkalemia
CORRECT ANSWER : B
Rationale: Clarithromycin is a potent inhibitor of P-glycoprotein, an efflux transporter in the gut
and kidneys. Inhibiting this transporter leads to significantly increased absorption and
decreased renal clearance of digoxin, a narrow therapeutic index drug, placing the patient at
high risk for digitalis toxicity. Options A, C, and D are incorrect because digoxin is not
primarily metabolized by CYP3A4, and the primary mechanism of this specific interaction is P-
glycoprotein inhibition, not induction or tubular secretion competition causing hyperkalemia.
2. A patient presents with Type 2 Diabetes and a history of chronic heart failure (NYHA Class III).
Which medication should be avoided as first-line therapy?
A. Metformin
B. Empagliflozin
C. Pioglitazone
D. Sitagliptin
CORRECT ANSWER : C
Rationale: Pioglitazone is a thiazolidinedione that causes fluid retention, which can exacerbate
or precipitate congestive heart failure. Metformin is generally the first-line choice;
Empagliflozin is beneficial in heart failure; Sitagliptin is weight-neutral and safe in heart failure.
Option C is the only choice that poses a direct, clinically significant risk of worsening heart
failure due to sodium and water retention.
3. Which mechanism of action best explains the efficacy of SSRIs in the treatment of major
depressive disorder, despite the rapid increase in synaptic serotonin?
A. Downregulation of postsynaptic serotonin receptors
B. Inhibition of MAO-A in the synaptic cleft
C. Desensitization and downregulation of presynaptic 5-HT1A autoreceptors
D. Immediate increase in brain-derived neurotrophic factor (BDNF)
CORRECT ANSWER : C
, Rationale: The delayed clinical response to SSRIs is attributed to the time required for the
presynaptic 5-HT1A autoreceptors to desensitize and downregulate due to chronic exposure to
increased synaptic serotonin. This removal of the "negative feedback" inhibition allows for
sustained, enhanced firing of serotonergic neurons. Options A, B, and D do not accurately
describe the primary mechanism explaining the therapeutic lag of SSRIs.
4. A patient on warfarin for atrial fibrillation is diagnosed with a DVT and requires a significant
change in diet involving high intake of leafy greens. How should the clinician adjust the
monitoring plan?
A. Increase warfarin dose immediately to compensate for vitamin K intake
B. Discontinue warfarin and switch to a DOAC
C. Monitor INR closely and adjust warfarin dose based on steady-state intake patterns
D. Prescribe prophylactic vitamin K supplementation
CORRECT ANSWER : C
Rationale: Sudden changes in dietary vitamin K intake can significantly impact INR, but the goal
is consistency rather than avoidance. The clinician must monitor the INR to determine if the new
dietary pattern has shifted the patient's requirement. Increasing the dose (A) without data is
dangerous; switching to a DOAC (B) may be an option but doesn't address the current
management; prophylactic vitamin K (D) is not the standard approach for dietary management.
5. When prescribing a beta-blocker for a patient with asthma, which agent is preferred due to its
pharmacokinetic profile?
A. Propranolol
B. Metoprolol succinate
C. Carvedilol
D. Nadolol
CORRECT ANSWER : B
Rationale: Metoprolol succinate is a cardioselective (beta-1) blocker and is less likely to cause
bronchoconstriction at lower doses compared to non-selective agents. Propranolol, Carvedilol,
and Nadolol are non-selective (blocking both beta-1 and beta-2 receptors) and pose a significant
risk of inducing bronchospasm in patients with reactive airway disease.
6. A patient is prescribed vancomycin for MRSA. What is the pharmacological basis for monitoring
trough levels?
, A. To prevent infusion-related anaphylaxis
B. To ensure peak concentrations exceed the MIC
C. To maintain therapeutic drug concentration while minimizing the risk of nephrotoxicity
D. To track the elimination half-life of the drug in real-time
CORRECT ANSWER : C
Rationale: Vancomycin-associated nephrotoxicity is strongly correlated with high trough
concentrations (typically >15-20 mcg/mL). Monitoring troughs ensures the drug reaches
effective concentrations for bacterial clearance without exceeding the safety threshold for renal
tubular injury. Options A, B, and D are incorrect as they do not represent the clinical rationale
for steady-state trough monitoring.
7. A patient with Parkinson’s disease develops psychotic symptoms. Which agent is the most
appropriate to manage these symptoms with the least risk of worsening motor function?
A. Haloperidol
B. Risperidone
C. Olanzapine
D. Pimavanserin
CORRECT ANSWER : D
Rationale: Pimavanserin is a selective serotonin inverse agonist (SSIA) that acts on 5-HT2A
receptors and does not exhibit appreciable affinity for dopamine receptors, making it ideal for
Parkinson's disease psychosis. Haloperidol, Risperidone, and Olanzapine are dopamine
antagonists that worsen motor symptoms by blocking D2 receptors in the nigrostriatal pathway.
8. Which mechanism accounts for the increased risk of hyponatremia when using Selective
Serotonin Reuptake Inhibitors (SSRIs) in elderly patients?
A. Enhanced ADH secretion via central serotonin stimulation
B. Renal sodium wasting due to prostaglandin inhibition
C. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
D. Reduced aldosterone sensitivity in the distal convoluted tubule
CORRECT ANSWER : C
